Testimony Before the FDA’s Vaccines and Related Biological Products Advisory Committee Regarding the EUA of the Moderna-NIH COVID-19 Vaccine
In testimony before a meeting of the Food and Drug Administration’s (FDA’s) Vaccines and Related Biological Products Advisory Committee, Public Citizen agreed with the need for an Emergency Use Authorization (EUA) for the Moderna-NIH COVID-19 vaccine, but argued that the fact sheet for recipients of the vaccine should advise recipients to continue following public health guidelines for wearing masks and other personal protective equipment and for social distancing to prevent transmission of the coronavirus.
See Public Citizen’s other work on the coronavirus pandemic.